Structure-Activity Relationship of a Pyrrole Based Series of PfPKG Inhibitors as Anti-Malarials. Read more about Structure-Activity Relationship of a Pyrrole Based Series of PfPKG Inhibitors as Anti-Malarials.
Kinetic characterization of human mRNA guanine-N7 methyltransferase. Read more about Kinetic characterization of human mRNA guanine-N7 methyltransferase.
Back-pocket optimization of 2-aminopyrimidine-based macrocycles leads to potent dual EPHA2/GAK kinase inhibitors with antiviral activity. Read more about Back-pocket optimization of 2-aminopyrimidine-based macrocycles leads to potent dual EPHA2/GAK kinase inhibitors with antiviral activity.
Tom20 gates PINK1 activity and mediates its tethering of the TOM and TIM23 translocases upon mitochondrial stress. Read more about Tom20 gates PINK1 activity and mediates its tethering of the TOM and TIM23 translocases upon mitochondrial stress.
Development of Selective Pyrido[2,3-d]pyrimidin-7(8H)-one-Based Mammalian STE20-Like (MST3/4) Kinase Inhibitors. Read more about Development of Selective Pyrido[2,3-d]pyrimidin-7(8H)-one-Based Mammalian STE20-Like (MST3/4) Kinase Inhibitors.
Identification of high-performing antibodies for Vacuolar protein sorting-associated protein 35 (hVPS35) for use in Western Blot, immunoprecipitation and immunofluorescence. Read more about Identification of high-performing antibodies for Vacuolar protein sorting-associated protein 35 (hVPS35) for use in Western Blot, immunoprecipitation and immunofluorescence.
Big data and benchmarking initiatives to bridge the gap from AlphaFold to drug design. Read more about Big data and benchmarking initiatives to bridge the gap from AlphaFold to drug design.
Discovery of the sEH Inhibitor Epoxykynin as a Potent Kynurenine Pathway Modulator. Read more about Discovery of the sEH Inhibitor Epoxykynin as a Potent Kynurenine Pathway Modulator.
Structure-guided drug discovery: back to the future. Read more about Structure-guided drug discovery: back to the future.
Discovery of Conformationally Constrained ALK2 Inhibitors. Read more about Discovery of Conformationally Constrained ALK2 Inhibitors.
